STIM
Neuronetics, Inc. Common Stock
stockNASDAQ
with neurostar advanced therapy, neuronetics, inc., is the market leader in transcranial magnetic stimulation technology for the treatment of major depressive disorder. based in malvern, pa, we are a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using mri-strength magnetic field pulses. we are the first company to have a non-systemic and non-invasive depression treatment cleared by the fda for patients who have not benefited from prior antidepressant medication. neuronetics markets neurostar advanced therapy throughout the united states and select markets around the world. if you have questions or comments about neurostar, please e-mail us at customersupport@neuronetics.com. for u.s. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.95 | 2026-10-15 | +7.38% | 3.438 |
| 1M | 2.91 | 2026-09-22 | -28.05% | 2.851 |
| 3M | 1.93 | 2026-07-22 | +8.49% | 1.859 |
| 6M | 1.59 | 2026-04-22 | +31.69% | 1.821 |
| 1Y | 2.93 | 2025-10-22 | -28.54% | 2.178 |
| 2Y | 1.00 | 2024-10-22 | +109.39% | — |
| 5Y | 5.32 | 2021-10-22 | -60.64% | 1.446 |
Neuronetics, Inc. Common Stock (NASDAQ:STIM) stock price today is $2.09, and today's volume is 644,091. STIM is up 4.174% today. The 30 day average volume is 1.03M. STIM market cap is $159.55M with 76.20M shares outstanding.